Document is current
Any future updates will be listed below
-
Authors
David, Sascha https://orcid.org/0000-0002-8231-0461
Rimmelé, Thomas
Joannidis, Michael
Girardis, Massimo
Pickkers, Peter
Nielsen, Nathan D.
Buhlmann, Alix
Molnar, Zsolt
Ostermann, Marlies
Kielstein, Jan T.
Wendel-Garcia, Pedro David
Bode, Christian
Stahl, Klaus
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 13 August 2025
Accepted: 17 October 2025
First Online: 21 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: SD, CB and KS are principal investigators of EXCHANGE-2. This trial tests plasma exchange in septic shock and is supported by the German Research Foundation (DFG DA 1209/7–1) and by Octapharma. SD and KS are supported with an unrestricted research grant from Cytosorbents. SD is an advisor for Santersus, Vantive and Octapharma. TR has recently received lecture fees at scientific conferences from Jafron, Vantive, Fresenius Medical Care, Cytosorbents, Estor and Nikkiso. MO has received research funding from Baxter and Biomerieux (paid to institution). MJ has received honoraria and/or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, Biomerieux, and Novartis. ZM has received lecture and consultation honoraria from CytoSorbents, ThermoFisher. MG has received honoraria for speaking at conferences from Estor and Fresenius.
